Santicioli P, Giuliani S, Patacchini R, Tramontana M, Criscuoli M, Maggi C A
Department of Pharmacology, Menarini Ricerche, Florence, Italy.
Naunyn Schmiedebergs Arch Pharmacol. 1997 Nov;356(5):678-88. doi: 10.1007/pl00005105.
We have characterized the action of the novel, water-soluble, tachykinin NK2 receptor antagonist MEN 11420 ([Asn(2-AcNH-beta-D-Glc)-Asp-Trp-Phe-Dap-Leu] c(2 beta-5 beta)) on the circular muscle of the guinea-pig and human colon in vitro and on the guinea-pig colon in vivo. In organ bath experiments on guinea-pig colon MEN 11420 produced a concentration-dependent rightward shift of the concentration-response curve to the NK2 receptor selective agonist, [beta Ala8]neurokinin A (NKA) (4-10) with a pKB value of 8.1. Up to 1 microM MEN 11420 had no effect on the concentration-response curve to methacholine, to the NK1 receptor selective agonist, [Sar9]substance P (SP) sulfone, to the NK3 receptor selective agonist, senktide, or on the response to exogenous SP. The response to exogenous NKA was inhibited, although the shift of the concentration-response curve to NKA produced by MEN 11420 at 1 microM (dose ratio 5.3) was much smaller than that produced against [beta Ala8]NKA (4-10) (dose ratio 102), presumably because NKA also stimulates NK1 receptors at relatively low concentrations. In sucrose gap, MEN 11420 concentration-dependently inhibited both depolarization (IC50 0.34 microM) and contraction (IC50 = 0.32 microM) produced by [beta Ala8]NKA (4-10) (0.3 microM for 10 s) in the guinea-pig colon without affecting the corresponding responses produced by [Sar9]SP sulfone. When similar experiments were performed in the circular muscle of the human colon MEN 11420 concentration-dependently inhibited both depolarization and contraction induced by [beta Ala8]NKA(4-10) with IC50s of 99 and 75 nM, respectively. MEN 11420 (1 microM) had no effect on the nonadrenergic noncholinergic (NANC) depolarization and contraction produced by a short period of electrical field stimulation (EFS, 10 Hz for 1 s) in the guinea-pig colon and selectively inhibited the sustained component of depolarization produced during a prolonged period of EFS (3 Hz for 3 min), without affecting the concomitant depolarization. Nifedipine (1 microM) eliminated the NANC contraction to a short period of EFS and the phasic contraction in response to a prolonged period of EFS. MEN 11420 (1 microM) abolished the nifedipine-resistant NANC contraction produced by prolonged period of electrical field stimulation (EFS, 3 Hz for 3 min). All electrical and mechanical NANC responses to EFS which were resistant to MEN 11420, either in the absence or presence of nifedipine, were abolished by the subsequent application of the NK1 receptor antagonist, SR 140333 (1 microM). Up to 3 microM, MEN 11420 had no significant effect on the cholinergic excitatory junction potential or the NANC inhibitory junction potential evoked by single pulse EFS, nor did it affect membrane conductance. In urethane-anaesthetized guinea-pigs MEN 11420 (10-100 nmol/kg i.v.) produced a dose-dependent and long lasting (> 3 h) inhibition of the contractile response (15 +/- 2 mmHg) of the proximal colon induced by [beta Ala8]NKA (4-10) (3 nmol/kg i.v.). MEN 11420 (300 nmol/kg i.v.) did not affect the contraction produced by [Sar9]SP sulfone. MEN 11420 (300 nmol/kg) produced a limited (Emax about 40% inhibition) and transient (recovery within 60 min) inhibition of the atropine- and hexamethonium-sensitive phasic contractions of the proximal colon induced by threshold distension of a colonic balloon. On the other hand, MEN 11420 (10-300 nmol/kg i.v.) produced a dose-dependent complete and prolonged (> 2 h from administration) inhibition of the atropine-resistant and hexamethonium-sensitive phasic contraction induced by suprathreshold distension of the colonic balloon. We conclude that MEN 11420 is a potent and selective tachykinin NK2 receptor antagonist devoid of significant inhibitory activity toward excitatory transmission mediated via tachykinin NK1 or muscarinic receptors. The present findings indicate that SP and NKA are likely involved in the preferential activation of NK1 and NK2 receptors during tachykininergi
我们已对新型水溶性速激肽NK2受体拮抗剂MEN 11420([Asn(2 - AcNH - β - D - Glc) - Asp - Trp - Phe - Dap - Leu] c(2β - 5β))在豚鼠和人结肠环形肌体外以及豚鼠结肠体内的作用进行了表征。在豚鼠结肠的器官浴实验中,MEN 11420使浓度 - 反应曲线浓度依赖性地向右移动至NK2受体选择性激动剂[βAla8]神经激肽A(NKA)(4 - 10),pKB值为8.1。高达1 μM的MEN 11420对乙酰甲胆碱、NK1受体选择性激动剂[Sar9]P物质(SP)砜、NK3受体选择性激动剂senktide的浓度 - 反应曲线或对外源性SP的反应均无影响。对外源性NKA的反应受到抑制,尽管1 μM的MEN 11420使浓度 - 反应曲线向NKA移动(剂量比5.3)远小于对[βAla8]NKA(4 - 10)产生的移动(剂量比102),推测是因为NKA在相对低浓度时也刺激NK1受体。在蔗糖间隙实验中,MEN 11420浓度依赖性地抑制了[βAla8]NKA(4 - 10)(以0.3 μM作用10 s)在豚鼠结肠中产生的去极化(IC50 0.34 μM)和收缩(IC50 = 0.32 μM),而不影响[Sar9]SP砜产生的相应反应。当在人结肠环形肌中进行类似实验时MEN 11420浓度依赖性地抑制了[βAla8]NKA(4 - 10)诱导的去极化和收缩,IC50分别为99和75 nM。MEN 11420(1 μM)对豚鼠结肠中短时间电场刺激(EFS,1 Hz持续1 s)产生的非肾上腺素能非胆碱能(NANC)去极化和收缩无影响,并选择性地抑制长时间EFS(3 Hz持续3 min)期间产生的去极化的持续成分,而不影响伴随的去极化。硝苯地平(1 μM)消除了对短时间EFS的NANC收缩以及对长时间EFS的相性收缩。MEN 11420(1 μM)消除了长时间电场刺激(EFS,3 Hz持续3 min)产生的对硝苯地平耐药的NANC收缩。在不存在或存在硝苯地平情况下,所有对EFS的电和机械NANC反应若对MEN 11420耐药,随后应用NK1受体拮抗剂SR 140333(1 μM)均可将其消除。高达3 μM时,MEN 11420对单脉冲EFS诱发的胆碱能兴奋性接头电位或NANC抑制性接头电位无显著影响,对膜电导也无影响。在乌拉坦麻醉的豚鼠中,MEN 11420(10 - 100 nmol/kg静脉注射)对[βAla8]NKA(4 - 10)(3 nmol/kg静脉注射)诱导的近端结肠收缩反应(15±2 mmHg)产生剂量依赖性且持久(> 3 h)的抑制。MEN 11420(300 nmol/kg静脉注射)不影响[Sar9]SP砜产生的收缩。MEN(300 nmol/kg)对结肠球囊阈值扩张诱导的近端结肠的阿托品和六甲铵敏感的相性收缩产生有限(最大抑制约为40%)且短暂(60 min内恢复)的抑制。另一方面,MEN 11420(10 - 300 nmol/kg静脉注射)对结肠球囊超阈值扩张诱导产生的阿托品耐药和六甲铵敏感的相性收缩产生剂量依赖性的完全且持久(给药后> 2 h)的抑制。我们得出结论,MEN 11420是一种强效且选择性的速激肽NK2受体拮抗剂,对通过速激肽NK1或毒蕈碱受体介导的兴奋性传递无显著抑制活性。目前的研究结果表明,在速激肽能神经传递过程中SP和NKA可能分别优先激活NK1和NK2受体。